(2013). An economic evaluation of trastuzumab as adjuvant treatment of early HER2-positive breast cancer patients in Colombia.
Chicago Style (17th ed.) CitationAn Economic Evaluation of Trastuzumab as Adjuvant Treatment of Early HER2-positive Breast Cancer Patients in Colombia. 2013.
MLA (8th ed.) CitationAn Economic Evaluation of Trastuzumab as Adjuvant Treatment of Early HER2-positive Breast Cancer Patients in Colombia. 2013.
Warning: These citations may not always be 100% accurate.
